JP2002516321A - インスリン耐性および高血糖の治療に有用なベンゾチオフェン、ベンゾフラン、およびインドール - Google Patents
インスリン耐性および高血糖の治療に有用なベンゾチオフェン、ベンゾフラン、およびインドールInfo
- Publication number
- JP2002516321A JP2002516321A JP2000550841A JP2000550841A JP2002516321A JP 2002516321 A JP2002516321 A JP 2002516321A JP 2000550841 A JP2000550841 A JP 2000550841A JP 2000550841 A JP2000550841 A JP 2000550841A JP 2002516321 A JP2002516321 A JP 2002516321A
- Authority
- JP
- Japan
- Prior art keywords
- carbon atoms
- dimethyl
- naphtho
- bromo
- thiophen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/74—Naphthothiophenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7671298A | 1998-05-12 | 1998-05-12 | |
US09/076,712 | 1998-05-12 | ||
PCT/US1999/010209 WO1999061435A1 (en) | 1998-05-12 | 1999-05-10 | Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002516321A true JP2002516321A (ja) | 2002-06-04 |
Family
ID=22133746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000550841A Pending JP2002516321A (ja) | 1998-05-12 | 1999-05-10 | インスリン耐性および高血糖の治療に有用なベンゾチオフェン、ベンゾフラン、およびインドール |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1077969A1 (xx) |
JP (1) | JP2002516321A (xx) |
KR (1) | KR20010043539A (xx) |
CN (1) | CN1308626A (xx) |
AR (1) | AR015294A1 (xx) |
AU (1) | AU756337B2 (xx) |
BG (1) | BG104918A (xx) |
BR (1) | BR9911779A (xx) |
CA (1) | CA2330620A1 (xx) |
EA (1) | EA200001175A1 (xx) |
EE (1) | EE200000653A (xx) |
HR (1) | HRP20000767A2 (xx) |
HU (1) | HUP0101792A3 (xx) |
ID (1) | ID26244A (xx) |
IL (1) | IL139132A0 (xx) |
NO (1) | NO20005677L (xx) |
PL (1) | PL344081A1 (xx) |
SK (1) | SK16992000A3 (xx) |
TR (1) | TR200003333T2 (xx) |
TW (1) | TW510900B (xx) |
WO (1) | WO1999061435A1 (xx) |
ZA (1) | ZA200005961B (xx) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006508082A (ja) * | 2002-10-14 | 2006-03-09 | クラリアント・ライフ・サイエンス・モレキユールズ(イタリア)・エツセ・ピー・アー | 2,5−二置換3−アルキルチオフェンの調製方法 |
JP2012511558A (ja) * | 2008-12-10 | 2012-05-24 | ザ・ユニヴァーシティ・オヴ・ダンディー | 疼痛の治療で使用するための化合物 |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002018363A2 (en) * | 2000-08-29 | 2002-03-07 | Abbott Laboratories | 3-phenyl-propanoic acid derivatives as protein tyrosine phosphatase inhibitors |
US6472545B2 (en) | 2000-08-29 | 2002-10-29 | Abbott Laboratories | Protein tyrosine phosphatase inhibitors |
WO2002026707A1 (en) * | 2000-09-26 | 2002-04-04 | Biovitrum Ab | Novel compounds |
US6498182B2 (en) | 2000-09-26 | 2002-12-24 | Biovitrum Ab | Compounds |
US6969730B2 (en) | 2001-03-16 | 2005-11-29 | Abbott Laboratories | Amines as histamine-3 receptor ligands and their therapeutic applications |
WO2002098409A1 (en) * | 2001-06-07 | 2002-12-12 | Wyeth | Combination therapy for type ii diabetes or syndrome x |
US20030013709A1 (en) * | 2001-06-07 | 2003-01-16 | Wyeth | Combination of a PTPase inhibitor and an alpha-glucosidase inhibitor |
WO2002098410A1 (en) * | 2001-06-07 | 2002-12-12 | Wyeth | Combination of a ptpase inhibitor and a sulfonylurea agent |
US20020198203A1 (en) * | 2001-06-07 | 2002-12-26 | Wyeth | Combination of a PTPase inhibitor and a thiazolidinedione agent |
WO2002098408A1 (en) * | 2001-06-07 | 2002-12-12 | Wyeth | Ptpase inhibitors for improving cardiovascular risk profile |
WO2002100398A1 (en) * | 2001-06-07 | 2002-12-19 | Wyeth | Combination of a ptpase inhibitor and an ace inhibitor |
WO2002100397A1 (en) * | 2001-06-07 | 2002-12-19 | Wyeth | COMBINATION OF A PTPase INHIBITOR AND AN ANTILIPEMIC AGENT |
US20020198201A1 (en) * | 2001-06-07 | 2002-12-26 | Wyeth | Combination of a PTPase inhibitor and an aldose reductase inhibitor |
WO2002098414A1 (en) * | 2001-06-07 | 2002-12-12 | Wyeth | Methods using ptpase inhibitors and insulin |
US7074817B2 (en) | 2001-06-20 | 2006-07-11 | Wyeth | Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
TWI224101B (en) | 2001-06-20 | 2004-11-21 | Wyeth Corp | Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
US7022730B2 (en) | 2001-10-19 | 2006-04-04 | Transtech Pharma, Inc. | Bis-heteroaryl alkanes as therapeutic agents |
WO2003048140A1 (fr) | 2001-12-03 | 2003-06-12 | Japan Tobacco Inc. | Compose azole et utilisation medicinale de celui-ci |
DE60306548T2 (de) | 2002-12-10 | 2007-06-21 | Wyeth | Substituierte 3-carbonyl-1-yl-essigsäure-derivate als plasminogen aktivator inhibitor(pai-1) inhibitoren |
DE60327550D1 (de) | 2002-12-10 | 2009-06-18 | Wyeth Corp | Substituierte indoloxoacetylaminoessigsäurederivate als inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1) |
UA80453C2 (en) | 2002-12-10 | 2007-09-25 | Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
DE60306547T2 (de) | 2002-12-10 | 2007-06-28 | Wyeth | Substituierte 3-alkyl- und 3-arylalkyl-1h-indol-1-yl-essigsäure-derivate als plasminogen-aktivator |
EP1569901B1 (en) | 2002-12-10 | 2008-10-15 | Wyeth | ARYL, ARYLOXY, AND ALKYLOXY SUBSTITUTED i 1H /i -INDOL-3-YL GLYOXYLIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) |
US7718377B2 (en) | 2003-05-29 | 2010-05-18 | Kyoto Pharmaceutical Industries, Ltd. | Insulin resistance curative and method of screening the same |
US7504401B2 (en) | 2003-08-29 | 2009-03-17 | Locus Pharmaceuticals, Inc. | Anti-cancer agents and uses thereof |
US7446201B2 (en) | 2003-09-25 | 2008-11-04 | Wyeth | Substituted heteroaryl benzofuran acids |
US7265148B2 (en) | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
US7268159B2 (en) | 2003-09-25 | 2007-09-11 | Wyeth | Substituted indoles |
US7411083B2 (en) | 2003-09-25 | 2008-08-12 | Wyeth | Substituted acetic acid derivatives |
US7332521B2 (en) | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
US7141592B2 (en) | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
US7582773B2 (en) | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
US7351726B2 (en) | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
US7163954B2 (en) | 2003-09-25 | 2007-01-16 | Wyeth | Substituted naphthyl benzothiophene acids |
US7442805B2 (en) | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
US7342039B2 (en) | 2003-09-25 | 2008-03-11 | Wyeth | Substituted indole oximes |
US7420059B2 (en) | 2003-11-20 | 2008-09-02 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
FR2862645B1 (fr) * | 2003-11-20 | 2007-06-22 | Merck Sante Sas | Composes antidiabetiques contenant des derives benzofuranes, benzothiophenes |
KR20070055563A (ko) | 2004-08-23 | 2007-05-30 | 와이어쓰 | 혈전증 및 심혈관 질병의 치료에 유용한 플라스미노겐활성화제 억제제 타입-1(pai-1)의 조절제로서의옥사졸로-나프틸 산 |
CN101263115A (zh) | 2005-08-17 | 2008-09-10 | 惠氏公司 | 经取代吲哚和其用途 |
JP5546451B2 (ja) | 2007-06-04 | 2014-07-09 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
AU2009256157B2 (en) | 2008-06-04 | 2014-12-18 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
WO2014057522A1 (en) | 2012-10-12 | 2014-04-17 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
US10441560B2 (en) | 2013-03-15 | 2019-10-15 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
EP2968245B1 (en) | 2013-03-15 | 2021-05-05 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
US10011637B2 (en) | 2013-06-05 | 2018-07-03 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
CN106749169B (zh) * | 2016-11-07 | 2020-04-21 | 浙江工业大学 | 一种Ertiprotafib的手性制备方法 |
CN107033122B (zh) * | 2017-05-19 | 2019-06-14 | 南方医科大学 | 一种n-芳基-2-噻吩酰胺类衍生物及其制备方法和用途 |
US20210115397A1 (en) | 2018-04-26 | 2021-04-22 | Tokyo Institute Of Technology | Method for promoting differentiation of pluripotent stem cells |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2015724B1 (xx) * | 1968-08-15 | 1973-01-12 | Parke Davis & Co | |
US3639422A (en) * | 1969-07-28 | 1972-02-01 | Parke Davis & Co | 4-phenylindole-1 (and 7)-acetic acids |
US3682976A (en) * | 1970-02-16 | 1972-08-08 | Parke Davis & Co | Phenyl benzofuran acetic acid compounds |
GB8417559D0 (en) * | 1984-07-10 | 1984-08-15 | Pfizer Ltd | Anti-diarrhoeal agents |
FR2599740B1 (fr) * | 1986-06-05 | 1988-08-12 | Rhone Poulenc Sante | Derives de benzo(b)thiophene de benzo(b)furannecarboxamides, leurs procedes de preparation et les medicaments les contenant |
JPH01135766A (ja) * | 1987-11-20 | 1989-05-29 | Tanabe Seiyaku Co Ltd | ビフェニル誘導体 |
US5110825A (en) * | 1989-12-28 | 1992-05-05 | Shionogi & Co., Ltd. | Benzofuran derivative |
US5340833A (en) * | 1992-05-01 | 1994-08-23 | Eisai Co., Ltd. | Urokinase inhibitors |
DE4425613A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
-
1999
- 1999-05-10 HU HU0101792A patent/HUP0101792A3/hu unknown
- 1999-05-10 CN CN99808367A patent/CN1308626A/zh active Pending
- 1999-05-10 PL PL99344081A patent/PL344081A1/xx not_active Application Discontinuation
- 1999-05-10 AU AU38939/99A patent/AU756337B2/en not_active Ceased
- 1999-05-10 EA EA200001175A patent/EA200001175A1/ru unknown
- 1999-05-10 WO PCT/US1999/010209 patent/WO1999061435A1/en not_active Application Discontinuation
- 1999-05-10 TR TR2000/03333T patent/TR200003333T2/xx unknown
- 1999-05-10 EE EEP200000653A patent/EE200000653A/xx unknown
- 1999-05-10 EP EP99921829A patent/EP1077969A1/en not_active Withdrawn
- 1999-05-10 SK SK1699-2000A patent/SK16992000A3/sk unknown
- 1999-05-10 KR KR1020007012649A patent/KR20010043539A/ko not_active Application Discontinuation
- 1999-05-10 JP JP2000550841A patent/JP2002516321A/ja active Pending
- 1999-05-10 IL IL13913299A patent/IL139132A0/xx unknown
- 1999-05-10 ID IDW20002311A patent/ID26244A/id unknown
- 1999-05-10 BR BR9911779-7A patent/BR9911779A/pt not_active IP Right Cessation
- 1999-05-10 TW TW088107532A patent/TW510900B/zh active
- 1999-05-10 CA CA002330620A patent/CA2330620A1/en not_active Abandoned
- 1999-05-12 AR ARP990102229A patent/AR015294A1/es unknown
-
2000
- 2000-10-24 ZA ZA200005961A patent/ZA200005961B/xx unknown
- 2000-11-07 BG BG104918A patent/BG104918A/bg unknown
- 2000-11-10 HR HR20000767A patent/HRP20000767A2/hr not_active Application Discontinuation
- 2000-11-10 NO NO20005677A patent/NO20005677L/no not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006508082A (ja) * | 2002-10-14 | 2006-03-09 | クラリアント・ライフ・サイエンス・モレキユールズ(イタリア)・エツセ・ピー・アー | 2,5−二置換3−アルキルチオフェンの調製方法 |
JP2012511558A (ja) * | 2008-12-10 | 2012-05-24 | ザ・ユニヴァーシティ・オヴ・ダンディー | 疼痛の治療で使用するための化合物 |
Also Published As
Publication number | Publication date |
---|---|
KR20010043539A (ko) | 2001-05-25 |
AR015294A1 (es) | 2001-04-18 |
AU3893999A (en) | 1999-12-13 |
EE200000653A (et) | 2002-04-15 |
NO20005677D0 (no) | 2000-11-10 |
TR200003333T2 (tr) | 2001-02-21 |
EP1077969A1 (en) | 2001-02-28 |
HRP20000767A2 (en) | 2001-10-31 |
ID26244A (id) | 2000-12-07 |
EA200001175A1 (ru) | 2001-06-25 |
IL139132A0 (en) | 2001-11-25 |
PL344081A1 (en) | 2001-09-24 |
HUP0101792A2 (hu) | 2002-01-28 |
SK16992000A3 (sk) | 2001-04-09 |
HUP0101792A3 (en) | 2003-01-28 |
CA2330620A1 (en) | 1999-12-02 |
ZA200005961B (en) | 2001-10-24 |
BG104918A (bg) | 2001-08-31 |
NO20005677L (no) | 2000-12-05 |
WO1999061435A1 (en) | 1999-12-02 |
CN1308626A (zh) | 2001-08-15 |
BR9911779A (pt) | 2001-02-06 |
AU756337B2 (en) | 2003-01-09 |
TW510900B (en) | 2002-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002516321A (ja) | インスリン耐性および高血糖の治療に有用なベンゾチオフェン、ベンゾフラン、およびインドール | |
US6251936B1 (en) | Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia | |
JP2002514638A (ja) | インスリン抵抗性および高血糖症の治療に有用な11−アリール−ベンゾ[b]ナフト[2,3−d]フラン類および11−アリール−ベンゾ[b]ナフト[2,3−d]チオフェン類 | |
JP4476624B2 (ja) | プラスミノゲンアクチベーターインヒビター1(pai−1)のインヒビターとしてのナフチルベンゾフラン誘導体 | |
US6166069A (en) | Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia | |
US5223510A (en) | Alkylaminoalkyl derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation and compositions containing them | |
US5721246A (en) | Heterobicyclic sulfonamide and sulfonic ester derivatives | |
EP1077967B1 (en) | Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia | |
JP2002514639A (ja) | ナフト[2,3−b]ヘテロアリー−4−イル誘導体 | |
JP2002514636A (ja) | インスリン抵抗性または高血糖症の治療に有用なフェニルオキソ−酢酸類 | |
EP1569900B1 (en) | Substituted 3-carbonyl-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
CA2538354A1 (en) | Substituted naphthyl benzothiophene acids | |
US6110962A (en) | 11-aryl-benzo[B]naphtho[2,3-D]furans and 11-aryl-benzo[B]naphtho[2,3-D]thiophenes useful in the treatment of insulin resistance and hyperglycemia | |
US6057316A (en) | 4-aryl-1-oxa-9-thia-cyclopenta[b]fluorenes | |
US6121271A (en) | Naphtho[2,3-B]heteroar-4-yl derivatives | |
US6001867A (en) | 1-aryl-dibenzothiophenes | |
US6221902B1 (en) | Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia | |
RU2387639C2 (ru) | Производные индола, содержащие ацетиленовую группу, в качестве ppar активаторов | |
JP2002514637A (ja) | インスリン耐性および高血糖症の治療に有用なビフェニルスルホニルアリールカルボン酸 | |
JP2002514631A (ja) | インスリン耐性および高血糖症の治療に有用なオキサゾール−アリール−カルボン酸 | |
US6281238B1 (en) | 4-aryl-1-oxa-9-thia-cylopenta[B]fluorenes | |
MXPA00011091A (en) | Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia | |
CZ20004182A3 (cs) | Deriváty benzothiofenu, benzofuranu a indolu | |
MXPA00011089A (en) | 11-aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-benzo[b]naphtho[2,3-d]thiophenes useful in the treatment of insulin resistance and hyperglycemia | |
MXPA00011086A (en) | Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |